维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="LAAN RF"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis : a randomized, controlled study 显示文摘	Laan RF van Riel PL van de Putte LB	1993	Ann Intern Med1993，119，10：	1
2	The C677T mutationin the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients显示文摘	van Ede AE Laan RF 810m HJ	2001	Arthritis Rheum2001，44，11：	1
3	Methotrexate-related pulmonary complications in rheumatoid arthritis显示文摘	Barrera P Laan RF van Riel PL	1994	Ann Rheum Dis1994，53，：	1
4	Bone density threshold and other predictors of vertebral fracture in patients re-ceiving oral glucocorticoid therapy 显示文摘	VAN STAA TP LAAN RF BARTON IP	2003	Arthritis Rheum2003，48，11：	1
5	Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy显示文摘	van Staa TP Laan RF Barton IP	2003	Arthritis Rheum2003，48，11：	1
6	Homocysteine and folate status in metho-trexate-treated patients with rheumatoid arthritis显示文摘	van Ede AE Laan RF Blom HJ Boers GH Haagsma CJ Thomas CM	2002	Rheu-matology(Oxford)2002，41，6：	1
7	Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis显示文摘	van Ede AE Laan RF Blom HJ	2002	Rheumatology (Oxford)2002，41，6：	1
8	Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy 显示文摘	Van Staa TP Laan RF Barton IP	2003	Arthritis Rheum2003，48，11：	1
9	Hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis显示文摘	Eijsbouts AM van den Hoogen FH Laan RF	2005	Clin Exp Rheumatol2005，23，5：	1
10	Homocysteine and folate status in methotrexate - treatd patient with rheumatoid arthritis显示文摘	VAN EDE AE LAAN RF BLOM HJ	2002	Rheumatology (Oxford)2002，41，6：	1
11	Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy显示文摘	Van Staa TP Laan RF Barton IP	2003	Arthritis Rheum2003，48，11：	1
12	Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women:a randomized trail显示文摘	REID DM HUGHES RA LAAN RF	2000	J Bone Miner Res2000，15，6：	1
13	Bone density threshold and other predictors of vertebral fracture inpatients receiving oral glucocorticoid therapy 显示文摘	Van Staa TP Laan RF Barton IP	2003	Arthritis Rheum2003，48，11：	1
14	Hypothalamic pituitary adrenal axis activity in patients with rhcumatoid arthritis显示文摘	EUHSBIYTS AM VAN DEN HOOGEN FH LAAN RF	2005	Clin Exp Rheumatol2005，23，5：	1
15	Hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis 显示文摘	Eijsbouts AM van den Hoogen FH Laan RF	2005	Clin Exp Rheumatol2005，23，5：	1
16	Hypothalamic-pituitary -adrenal axis activity in patients with rheumatoid arthritis 显示文摘	Eijsbouts AM van den Hoogen FH Laan RF	2005	Clin Exp Rheumatol2005，23，：	1
17	The C677T mutation in the methylenetetrahydrofolate reductase gene : a genetic risk factor for methotrexate - related elevation of liver enzymes in rheumatoid arthritis patients 显示文摘	van Ede AE Laan RF Blom HJ	2001	Arthritis Rheum2001，44，：	1
18	Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy显示文摘	Van Staa TP Laan RF Barton IP	2003	Arthritis Rheum2003，48，11：	1
19	Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial: European Corticosteroid-Induced Osteoporosis Treatment Study 显示文摘	Reid DM Hughes RA Laan RF	2000	J Bone Miner Res2000，15，6：	1
20	Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women:a randomized trail显示文摘	Reid DM Hughes RA Laan RF	2000	J Bone Miner Res2000，15，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示